Pfizer (PFE|$150.3B) - 2025 Q4 & Full Year Earnings Analysis скачать в хорошем качестве

Pfizer (PFE|$150.3B) - 2025 Q4 & Full Year Earnings Analysis

#PFE Pfizer 2025 Q4 & Full Year Earnings: Pfizer reported solid financial performance in Q4 2025, with an adjusted EPS of $0.66, beating analyst expectations. Revenue: $62.6 billion Adj. EPS: $0.66 vs. forecast $0.56 (6 analysts) 2026 Revenue Guidance: $59.5-$62.5 billion Strategic Pipeline Investments "With excellent execution in 2025, we delivered a solid financial performance and strengthened Pfizer’s foundation for future growth." - Dr. Albert Bourla, CEO If you enjoyed this video, please like, subscribe, and hit the notification bell to stay updated with our latest stock analysis and market insights. Leave a comment below with your thoughts on the video, and any other stocks you'd like us to cover. Check out our latest videos on more earnings: #MRK Merck 2025 Q4 & Full Year Earnings:    • Merck (MRK|$273.7B) - 2025 Q4 & Full Year ...   #EPD Enterprise Products Partners 2025 Q4 Earnings:    • Enterprise Products Partners (EPD|$71.8B) ...   #FLXS Flexsteel 2026 Q2 Earnings:    • Flexsteel (FLXS|$209.3M) - 2026 Q2 Earning...   #KFRC Kforce 2025 Q4 & Full Year Earnings:    • Kforce (KFRC|$597.4M) - 2025 Q4 & Full Yea...   #CSWC Capital Southwest 2026 Q3 Earnings:    • Capital Southwest (CSWC|$1.4B) - 2026 Q3 E...